Draft Workflow

Incoming Communication

Enrollment Update — Subjects 03-004 Through 03-007 Enrolled

Received: 02 Jul 2025 09:00 UTC

Site: 03 — Hospital Clínic de Barcelona

From: Lucía Moreno García (Study Coordinator)

Classification

Enrollment

Confidence: 95%

RULE-BASED vrules-v1.0

Classification Reasoning

Primary keyword match in subject: 'enrollment'

Channel: email | Direction: in

Text Block Suggestions

1st — Subject Withdrawal Acknowledgment

Dear {{CONTACT_NAME}}, We acknowledge the notification that Subject {{SUBJECT_ID}} at {{SITE_NAME}} (Site {{SITE_NUMBER...

Score: 1.50 | Category match: CAT-ENR; Phase match: any; Language match: en

formality=formal (+0.15)

2nd — Enrollment Status Update Request

Dear {{CONTACT_NAME}}, As part of our routine enrollment tracking for study PMCF-2024-CAT-001, we are requesting an upd...

Score: 1.45 | Category match: CAT-ENR; Language match: en

formality=formal (+0.15); detail_level=thorough (+0.10); opening_style=contextual (+0.05)

3rd — Enrollment Milestone Congratulation

Dear {{CONTACT_NAME}}, I am delighted to inform you that {{SITE_NAME}} (Site {{SITE_NUMBER}}) has reached a significant...

Score: 1.25 | Category match: CAT-ENR; Language match: en

opening_style=contextual (+0.05); closing_style=warm (+0.05)

Draft Response

Dear Lucía Moreno García,

We acknowledge the notification that Subject {{SUBJECT_ID}} at Hospital Clínic de Barcelona (Site 03) has withdrawn from study PMCF-2024-CAT-001.

Withdrawal Date: 16 Mar 2026
Reason for Withdrawal: {{WITHDRAWAL_REASON}}

Please ensure the following actions are completed at your site:

1. Complete the End of Study Visit procedures as outlined in Section 7.6 of the protocol, to the extent that the subject consents
2. Document the withdrawal reason in the subject's CRF and source records
3. Return or account for any outstanding investigational devices assigned to this subject
4. Confirm whether the subject consents to continued follow-up for safety endpoints, as described in Section 7.6.3 of the protocol

If the withdrawal was due to an adverse event or device-related concern, please ensure that the appropriate safety reporting procedures have been followed.

The subject's data collected prior to withdrawal remains part of the study dataset and will be included in the analysis in accordance with the statistical analysis plan.

Kind regards,
Sarah Mitchell
Clinical Research Associate
MedCore Clinical Research

Resolved 6 placeholder(s)

Unresolved: SUBJECT_ID, WITHDRAWAL_REASON